Nisa Investment Advisors’s Soleno Therapeutics SLNO Stock Holding History

Nisa Investment Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-419	Closed	-$14K	–	3174
2026 Q1	$14K	Sell	419 -89	-18%	-$3.49K	﹤0.01%	2129
2025 Q4	$23.5K	Sell	508 -31	-6%	-$1.7K	﹤0.01%	1877
2025 Q3	$36.4K	Hold	539	–	–	﹤0.01%	1724
2025 Q2	$45.2K	Buy	539 +400	+288%	+$29.9K	﹤0.01%	1618
2025 Q1	$9.93K	Buy	139 +31	+29%	+$1.51K	﹤0.01%	2095
2024 Q4	$4.86K	Buy	108 +42	+64%	+$2.18K	﹤0.01%	2284
2024 Q3	$3.33K	Buy	+66	New	+$3.16K	﹤0.01%	2304

Nisa Investment Advisors's SLNO Position: Q2 2026 in Review

Nisa Investment Advisors sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 419 shares — an estimated $14K sold.

Nisa Investment Advisors first reported a position in SLNO in Q3 2024 and held it in 7 quarters. The position peaked at $45.2K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Nisa Investment Advisors reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Nisa Investment Advisors sold 419 Soleno Therapeutics shares in Q2 2026, an estimated $14K.
Nisa Investment Advisors first reported a position in Soleno Therapeutics in Q3 2024 and held it in 7 quarters.
Nisa Investment Advisors's Soleno Therapeutics position peaked at $45.2K in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.